Back

Transcatheter aortic valve replacement in patients with previous mitral prostheses

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Biomarkers and phenotype in aortic stenosis Aortic valve disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Carlos Cortes

UNIVERSITY HOSPITAL MIGUEL SERVET, Zaragoza (Spain)

13 More presentations in this session

Presentation thumbnail
Prognostic impact of B-type natriuretic peptide after transcatheter aortic valve replacement in patients with severe aortic stenosis
Doctor K. Sato (Tsukuba, JP)
Abstract Slides
Presentation thumbnail
Cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of TAVI associated acute kidney injury
Doctor L. Gaede (Erlangen, DE)
Abstract Slides
Presentation thumbnail
Plasma ACE2 activity is a novel and independent predictor of all-cause mortality in patients with aortic stenosis.
Doctor J. Ramchand (Cleveland, US)
Abstract Slides
Presentation thumbnail
Apolipoprotein E and Paraoxonase 1 serum concentration and genetic polymorphism in aortic valve calcification
Professor O. Boeva (Stavropol, RU)
Presentation thumbnail
RANKL expression is increased in peripheral mononuclear cells of patients with severe aortic valve stenosis and promotes pro-calcific differentiation of valve cells
Doctor R. Buso (Treviso, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Biomarkers and phenotype in aortic stenosis

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources